These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 37315647)
1. Bioinformatics analysis and in vivo validation study of Ophiocordyceps sinensis (Berk.)G.H.Sungetal against lung adenocarcinoma. Zhang X; Wang M; Liang X; Wang J; Zhang M; Li C; Wei L; Bi H J Ethnopharmacol; 2023 Dec; 317():116739. PubMed ID: 37315647 [TBL] [Abstract][Full Text] [Related]
2. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment. Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737 [TBL] [Abstract][Full Text] [Related]
3. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma. Zeng Y; Pan Y; Zhang B; Luo Y; Tian J; Wang Y; Ju X; Wu J; Li Y Med Sci Monit; 2022 Jul; 28():e937131. PubMed ID: 35871777 [TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19. Zhang W; Yang Z; Zhou F; Wei Y; Ma X Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452 [TBL] [Abstract][Full Text] [Related]
5. Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis. Yang FR; Li SY; Hu XW; Li XR; Li HJ Drug Des Devel Ther; 2022; 16():2365-2382. PubMed ID: 35910781 [TBL] [Abstract][Full Text] [Related]
6. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
7. Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma. Zhao XY; Yang YY; Feng JL; Feng CL J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939253 [TBL] [Abstract][Full Text] [Related]
8. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses. Zhang K; Wang K; Zhang C; Teng X; Li D; Chen M BMC Cancer; 2022 Jun; 22(1):687. PubMed ID: 35733175 [TBL] [Abstract][Full Text] [Related]
9. Uncovering anti-influenza mechanism of Ophiocordyceps sinensis using network pharmacology, molecular pharmacology, and metabolomics. Zhou J; Wang M; Sun T; Zhou X; Wang J; Wang Y; Zhang R; Luo R; Yu H Medicine (Baltimore); 2023 Sep; 102(35):e34843. PubMed ID: 37657041 [TBL] [Abstract][Full Text] [Related]
10. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma. Wu Q; Wang YB; Che XW; Wang H; Wang W J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006 [TBL] [Abstract][Full Text] [Related]
11. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology]. Li JL; Hou W Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
13. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics. Ni KW; Sun GZ Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633 [TBL] [Abstract][Full Text] [Related]
14. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis. Zhang G; Dong R; Kong D; Liu B; Zha Y; Luo M Anticancer Agents Med Chem; 2022; 22(2):223-238. PubMed ID: 34238200 [TBL] [Abstract][Full Text] [Related]
15. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
16. Predicting potential therapeutic targets and small molecule drugs for early-stage lung adenocarcinoma. Yu Y; Li L; Luo B; Chen D; Yin C; Jian C; You Q; Wang J; Fang L; Cai D; Sun J Biomed Pharmacother; 2024 May; 174():116528. PubMed ID: 38555814 [TBL] [Abstract][Full Text] [Related]
17. Exploring the mechanisms of action of Zhang X; Wang M; Qiao Y; Shan Z; Yang M; Li G; Xiao Y; Wei L; Bi H; Gao T Ann Transl Med; 2022 Mar; 10(6):282. PubMed ID: 35434037 [TBL] [Abstract][Full Text] [Related]
18. Lung Adenocarcinoma Systems Biomarker and Drug Candidates Identified by Machine Learning, Gene Expression Data, and Integrative Bioinformatics Pipeline. Soyer SM; Ozbek P; Kasavi C OMICS; 2024 Aug; 28(8):408-420. PubMed ID: 38979602 [TBL] [Abstract][Full Text] [Related]
19. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma. Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation. Wang YC; Hui JR; Xiao G; Ma QL Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]